Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Diclofenamide

EU orphan designation number: EU/3/16/1616   
Active ingredient: Diclofenamide
Indication: Treatment of periodic paralysis
Sponsor: Prof. Michael Hanna
MRC Centre for Neuromuscular Diseases, 8-11 Queen Square, London, WC1N 3BG, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
19/02/2016 Orphan designation EMA/OD/199/15 (2016)1109 of 17/02/2016